Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man

Abstrakt

Three members of the aldo-keto reductase (AKR) superfamily were found and identified to mediate oracin carbonyl reduction in man